![](https://thedalesreport.com/wp-content/uploads/2024/07/WhatsApp-Image-2024-07-23-at-08.03.31.jpeg)
Cannara Biotech’s Q3 2024 Results: 27.6% Revenue Surge and Positive Net Income
The TDR Three Key Takeaways on Cannara Biotech’s Q3 2024 Financial Report: Significant Revenue Increase: Gross cannabis revenues rose by 27.6% to $26.2 million, driven by new provincial entries and product launches. Beats 2023 Revenue in 9 Months: Gross …